AI platform that automates CT scan analysis for oncology including tumor sizing, RECIST lesion classification, and body composition assessment.
Nucleo automates CT scan analysis for oncology care, enabling faster and more consistent cancer diagnostics. The platform covers three clinical use cases: body composition and sarcopenia assessment with automatic fat and muscle quantification, tumor lesion sizing with precise CT measurement, and target vs. non-target lesion classification according to RECIST criteria. Nucleo is used at Stanford Hospital, Cedars-Sinai, UCI Health, Weill Cornell, and other leading US and global hospitals. Nucleo is a product of Nucleo.